35 results on '"Kusters, D Meeike"'
Search Results
2. Familial hypercholesterolemia in children and the importance of early treatment
3. Lipid metabolism during pregnancy: consequences for mother and child
4. Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN
5. Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis
6. Current and emerging monoclonal antibodies for treating familial hypercholesterolemia in children
7. CTCA in children with severe heterozygous familial hypercholesterolaemia: Screening for subclinical atherosclerosis
8. Lipid metabolism during pregnancy:Consequences for mother and child
9. HOFH is a life limiting condition: The life journey of deceased HOFH patients in the HICC registry
10. Efficacy of lipoprotein apheresis initiated in childhood on cardiovascular outcomes in patients with homozygous FH: Data from two international registries
11. Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPN
12. Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study
13. Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia
14. Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia
15. Inheritance pattern of familial hypercholesterolemia and markers of cardiovascular risk
16. Response by Kusters et al to Letter Regarding Article, “Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)”
17. Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence
18. Follow-Up of Children Diagnosed with Familial Hypercholesterolemia in a National Genetic Screening Program
19. Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?
20. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome
21. Advances in familial hypercholesterolaemia in children
22. Statin use during pregnancy: a systematic review and meta-analysis
23. Statins for Familial Hypercholesterolemia from Childhood. Reply
24. 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
25. Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia
26. Statin Initiation During Childhood in Patients With Familial Hypercholesterolemia
27. Ten-Year Follow-up After Initiation of Statin Therapy in Children With Familial Hypercholesterolemia
28. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome
29. Offspring from mothers versus fathers with familial hypercholesterolemia: is there a difference in cardiovascular risk?
30. Molecular Basis of Autosomal Dominant Hypercholesterolemia
31. Treatment of dyslipidaemia in childhood
32. THE AUTHORS REPLY.
33. Statin Initiation During Childhood in Patients With Familial Hypercholesterolemia Consequences for Cardiovascular Risk
34. Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPN.
35. Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.